The Fund will pursue a focused investment strategy predicated on investing in established North Africa-based healthcare companies with demonstrated track record, solid growth prospects, and strong commitment to environmental, social and governance (ESG) best practices, with the aim of growing businesses within their local markets and regionalizing successful North African models to the broader African continent. Through investment, the Fund aspires to develop Sub-Saharan Africa’s under-served and fast-growing healthcare sector, with the aim of building solid integrated platforms across the healthcare value chain. The Fund expects to add significant value to its investee companies via strategic and operational support extended by its seasoned management team. The Fund aims to achieve significant cross-border synergies, operational optimization, and implementation of ESG best practices and policies across its portfolio of investments.
The Fund’s investment approach is predicated on providing growth capital by investing in controlling stakes (and on selective basis, in controlled minority stakes) in companies operating in the segments of (i) hospitals (general & specialized), (ii) laboratory and diagnostic centres/imaging specialized labs, (iii) pharmaceuticals manufacturing and other complimentary healthcare sub-segments.
The Fund targets investments that demonstrate the following core qualities in line with its investment criteria:
Historically Africa has had to bear more than 25% of the global infectious disease burden:
The continent’s underdeveloped healthcare infrastructure suffers from a shortage of healthcare facilities and qualified healthcare providers:
However, a more promising macro picture could spur growth in the African healthcare sector, creating a significant role for private healthcare providers to play in these large and growing economies: